Jerini: New look at peptides

Peptides have attracted researchers because they're easy and cheap to manufacture compared to proteins, although they haven't made good drugs because they are poorly absorbed and rapidly degraded and excreted. But they can serve as a starting point for the development of small molecules, and many companies now are trying to systematically transform peptides into peptidomimetics or small molecules that can be administered orally or even nasally.

Peptide and peptidomimetics specialist Jerini AG sees itself well positioned to take advantage of this renewed interest. ...